glp 1 alcohol reduction GLP-1 Drug Semaglutide Substantially Reduced Heavy Consumption and Weight in Patients with Alcohol Use Disorder and Obesity GLP-1 RAs may reduce alcohol-related

Presented for research literature review only Rajasekar P et al

Medications that can enhance the activity of insulin (so-called incretin mimetics) can help to overcome insulin resistance caused by SGAs (and potentially by other psychotropic medications) and essentially lead to weight loss through enhanced fuel efficiency. Metformin, typically dosed up to 1,000 mg twice daily with meals, has increasingly become recognized as a first-line strategy to attenuate weight gain and glycemic dysregulation from SGAs via its ability to reduce insulin resistance

Whether vitamin C enhances the ability of a bacterium to damage the protective chemicals found in the bladder wall

Melanoma is the most common cancer diagnosed in young Australians aged 1529 years, accounting for 15% of all cancers in this age group